Back

Sex differences in cardiorenometabolic syndrome across heart failure: prognostic impact in a low-middle income country

30 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Heart failure risk: from inflammation to prediction Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Antonio Jordan

National Institute of Cardiology, Mexico City (Mexico)

6 More presentations in this session

Presentation thumbnail
Sex differences in cardiovascular inflammation defined by high-sensitivity C-reactive protein across heart failure phenotypes: insights from POSEIDON
Professor S. Stoerk (Wuerzburg, DE)
Abstract
Presentation thumbnail
From desalination to deficiency: shifting magnesium-related mortality in heart failure patients
Doctor K. Faierstein (Ramat Gan, IL)
Abstract
Presentation thumbnail
Does evidence-based treatment recommendations implementation improve 1-year outcomes in patients with heart failure?
Doctor M. Anguita Gamez (Madrid, ES)
Abstract
Presentation thumbnail
Prevalence of high inflammatory risk across heart failure subtypes in Europe: a sub-analysis of the global POSEIDON study
Professor J. Muller-Ehmsen (Bremen, DE)
Abstract
Presentation thumbnail
Risk of major adverse cardiovascular events after RSV-related hospitalization among US adults with heart failure
Doctor D. Bhatt (New York City, US)
Abstract

Access the full session

Session thumbnail
Heart failure risk: from inflammation to prediction

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Sex differences in cardiorenal syndrome: insights from CARDIOREN registry
22 May 2023
thumbnail
Congress Presentation
Relationships between metabolic syndrome and outcomes in dilated cardiomyopathy.
22 May 2023
thumbnail
Congress Session
Solving the puzzle of heart failure treatment
18 May 2025
thumbnail
Congress Session
Redefining mineralocorticoid receptor antagonism in cardio-kidney-metabolic syndrome: from evidence to innovation
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources